IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지

Production of $TGF-{\beta}1$ as a Mechanism for Defective Antigen-presenting Cell Function of Macrophages Generated in vitro with M-CSF

  • Published : 2009.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Macrophages generated in vitro using macrophage-colony stimulating factor (M-CSF) and interleukin (IL)-6 from bone marrow cells (BM-Mp) are defective in antigen presenting cell (APC) function as shown by their ability to induce the proliferation of anti-CD3 mAb-primed syngeneic T cells. However, they do express major histocompatibility (MHC) class I and II molecules. accessory molecules and intracellular adhesion molecules. Here we demonstrate that the defective APC function of macrophages is mainly due to production of $TGF-{\beta}1$ by BM-Mp. Methods: Microarray analysis showed that $TGF-{\beta}1$ was highly expressed in BM-Mp, compared to a macrophage cell line, B6D. which exerted efficient APC function. Production of $TGF-{\beta}1$ by BM-Mp was confirmed by neutralization experiments of $TGF-{\beta}1$ as well as by real time-polymerase chain reaction (PCR). Results: Addition of $anti-TGF-{\beta}1$ monoclonal antibody to cultures of BM-Mp and anti-CD3 mAb-primed syngeneic T cells efficiently induced the proliferation of syngeneic T cells. Conversely, the APC function of B6D cells was almost completely suppressed by addition of $TGF-{\beta}1$. Quantitative real time-PCR analysis also confirmed the enhanced expression of $TGF-{\beta}1$ in BM-Mp. Conclusion: The defective APC function of macrophages generated in vitro with M-CSF and IL-6 was mainly due to the production of $TGF-{\beta}1$ by macrophages.

Keywords

References

  1. Jansen JH, Kluin-Nelemans JC, van Damme J, Weintjens GJ, Williemze R, Fibbe WE: Interleukin 6 is a pemissive factor for monocytic colony formation by human hematopoietic cells. J Exp Med 175;1151-1154, 1992 https://doi.org/10.1084/jem.175.4.1151
  2. Khalili H, Deshpande R, Chang MY: The defective antigen-presesnting activity of murine fetal macrophage cell lines. Immunol 92;487-493, 1997 https://doi.org/10.1046/j.1365-2567.1997.00369.x
  3. Smih W, Feldmann M, Londei M: Human marophages in duced in vitro by macrophage colony-stimulating factor are deficient in IL-12 production. Eur J Immunol 28;2498-2507, 1998 https://doi.org/10.1002/(SICI)1521-4141(199808)28:08<2498::AID-IMMU2498>3.0.CO;2-Q
  4. Lee CK, Kim JK, Kim Y, Lee MK, Kim K, Kang JK, Hofmeister R, Durum SK, Han SS: Generation of macrophages from early T progenitors in vitro. J Immunol 166;5964-5969, 2001 https://doi.org/10.4049/jimmunol.166.10.5964
  5. Holt PG, Oliver J, Bilyk N, McMenamin C, McMenamin PG, Kraal G, Thepen T: Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 177;397-407, 1993 https://doi.org/10.1084/jem.177.2.397
  6. Miyazaki T, Suzuki G, Yamamura K: The role of macrophages in antigen presentation and T cell tolerance. Int Immunol 5;1023-1033, 1993 https://doi.org/10.1093/intimm/5.9.1023
  7. Poulter LW, Janossy G, Power C, Sreenan S, Burke C: Immunological/physiological relationships in asthma: potential regulation by lung macrophages. Immunol Today 15;258-261, 1994 https://doi.org/10.1016/0167-5699(94)90004-3
  8. Munn DH, Pressey J, Beall AC, Hudes R, Alderson MR: Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. A potential mechanism of anti gen-specific peripheral lymphocyte deletion. J Immunol 156;523-532, 1996
  9. Surh CD, Sprent J: T-cell apoptosis detected in situ during positive and negative seletion in the thymus. Nature 372;100-103, 1994 https://doi.org/10.1038/372100a0
  10. Lee JK, Kim JK, Lee YR, Kim HS, Im SA, Kim K, Lee CK: Exposure to chemokines duing mature macrophages. ell Immunol 234;1-8, 2005 https://doi.org/10.1016/j.cellimm.2005.04.017
  11. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS: Transforming growth factor beta is and important immunomodulatory protein for human B lymphoytes. J Immunol 137;3850-3860, 1986
  12. Ristow HJ: BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation. Proc Natl Acad Sci U S A 83;5531-5533, 1986 https://doi.org/10.1073/pnas.83.15.5531
  13. Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Spom MB, Burlington DB, Lane HC, Fauci AS: Effets of transfoming gowth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136;3916-3920, 1986
  14. Kuppner MC, Hamou MF, Bodmer S, Fontana A, de Tribolet N: The gliblastoma-derived T-cell suppressor actor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells. Int J Caner 42;562-567, 1988 https://doi.org/10.1002/ijc.2910420416
  15. Wahl Sm, Hunt DA, Bansal G, McCartney-Francis N, Eliingsworth L, Allen JB: Bacterial cell wall-induced immynosuppression. Role of transforming growth factor beta. J Exp Med 168;1403-1417, 1988 https://doi.org/10.1084/jem.168.4.1403
  16. Miki R, Kadota K, Bono H, Mizuno Y, Tomaru Y, Caminci P, Itoh M, Shibata K, Kawai J, Konno H, Watanabe S, Sata K, Tokusumi Y, Kikuchi N, Ishii Y, Hamaguchi Y, Nishizuka I, Goto H, Nitanda H, Saomi S, Yoshiki A, Kusakabe M, DeRisi JL, Eisen MB, lyer VR, Brown PO, Muramatsu M, Shimada H, Okazaki Y, Hayashizaki Y: Delineating developmental and metabolic pathways in vivo by expresion profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays. Proc Natl Acad Sci U S A 98;2199-2204, 2001 https://doi.org/10.1073/pnas.041605498
  17. Liu W, Saint DA: A new quantitative methods of real time reverse transription polymerase chain reation asay based on stimulation of polymerase chain reaction kinetics. Anal Biochem 302;52-59, 2002 https://doi.org/10.1006/abio.2001.5530
  18. Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C, Blay JY: Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of intereukin-6 and macrophage colony-stimulating factor. Blood 92;4778-4791, 1998
  19. Cella M, Sallusto F, Lanzavecchin A:Origin Maturation and antigen pressenting fuction of dendritic cells. Curr Opin Immunol 9;10-16, 1997 https://doi.org/10.1016/S0952-7915(97)80153-7
  20. Sallusto F, Lanzavecchia A: Efiient pressentation of soluble antigen by ultured human dendritic cells is maintaied by granulocye/macrophage olony-stimulating factor plus in-terleukin 4 and ownregulate by tumor nerois fator alpha. J Exp Med 179;1109-1118, 1994 https://doi.org/10.1084/jem.179.4.1109
  21. Wong GG, Temple PA, Leary AC< Witek-Giannotti JS, Yang CY, Ciarletta AB, Chung M, Murtha P, Kriz R, Kaufman RJ, Ferenz CR, Sibley BS, Tunmer KJ, Hewick RM, Clark SC, Yanai N, Yamada M, Saito M, Motoyoshi K, Takaku F: Human CSF-1: moleular cloning and expression of 4-kbcDNA enodin the human urinay protein. Sciene 235;1504-1508, 1987 https://doi.org/10.1126/science.3493529
  22. Metcalf D: The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 67;257-267, 1986
  23. Espevik T, Figari I, Ranges GE, Palladino MA Jr: Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1. J Immunol 140;2312-2316, 1988
  24. Ohta M, Greenberger JS, Anklesaria P, Bassols A, Massaque J: Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells. Nature 329;539-541, 1987 https://doi.org/10.1038/329539a0
  25. Rangs GE, Figari IS, Espevik T, Palladino MA Jr: Inhibition of cytotoxic T cell development by transforming growth factor veta and reversal by recombinant tumor necrosis factor alpha. J Exp Med 166;991-998, 1987 https://doi.org/10.1084/jem.166.4.991
  26. Czamiecki CW, Chiu HH, Wong GH, McCabe SM, Palladino MA: Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. J Immuol 140;4217-4223, 1988